Retinoblastoma Patients With High Risk Ocular Pathological Features: Who Needs Adjuvant Therapy?

British Journal of Ophthalmology - United Kingdom
doi 10.1136/bjo.2003.037044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Neoadjuvant and Adjuvant Chemohormonal Therapy in Patients With High-Risk and Very High-Risk Prostate Cancer: Our Experience

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2018English

Retinoblastoma Regression Patterns Following Chemoreduction and Adjuvant Therapy in 557 Tumors

Archives of Ophthalmology
2009English

Ocular Toxicity of Intravitreal Melphalan for Retinoblastoma in Chinese Patients

BMC Ophthalmology
MedicineOphthalmology
2019English

Tratamento Conservador Em Retinoblastoma Intra-Ocular

Arquivos Brasileiros de Oftalmologia
MedicineOphthalmology
2003English

Adjuvant Endocrine Therapy in Premenopausal Patients

Breast Care
SurgeryOncology
2008English

Adjuvant Corticosteroid Therapy for Critically Ill Patients With COVID-19

2020English

Deletion (13)(q13q14.3) With Retinoblastoma: Confirmation and Extension of a Recognisable Pattern of Clinical Features in Retinoblastoma Patients With 13q Deletion.

Journal of Medical Genetics
Genetics
1987English

Melatonin as an Adjuvant Therapy in Patients With Rheumatoid Arthritis

British Journal of Clinical Pharmacology
Pharmacology
2008English

The Current State of Adjuvant Therapy Following Surgery for High-Risk Renal Cell Carcinoma

European Urology Focus
Urology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy